Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT06085482
PHASE1

A Phase I Study of LY3502970 in Healthy Participants

Sponsor: Eli Lilly and Company

View on ClinicalTrials.gov

Summary

The main purpose of this study is to evaluate how much of the study drug (LY3502970) and the radioactive substance 14C incorporated LY3502970 gets into the bloodstream, how its broken down, and how long it takes the body to get rid of it. The study will last up to approximately 9 weeks for each participant.

Official title: A Single-Group, Open-Label, Single-Period, Phase 1 Study to Determine the Absolute Bioavailability of LY3502970 in Healthy Participants

Key Details

Gender

All

Age Range

21 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

10

Start Date

2023-10-19

Completion Date

2024-01-05

Last Updated

2026-05-27

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

LY3502970

Administered orally

DRUG

[14C]-LY3502970

Administered IV

Locations (1)

Covance Clinical Research Inc

Madison, Wisconsin, United States